This inconclusive outcome has been termed CF transmembrane conductance regulator (CFTR) related metabolic syndrome (CRMS) or CF screen positive, inconclusive diagnosis (CRMS or CFSPID) [4]. Here, CFTR is linked to metabolic syndrome.